Growing evidence for the role of PAD enzymes in tumor progression, NET formation, and metastatic processes points to the significant therapeutic potential of this strategy, particularly in the context of combination therapies with immunotherapy [64]. This evidence concerns the gene PADI4 and neoplasm.